Regulation of PKD by the MAPK p38δ in Insulin Secretion and Glucose HomeostasisGrzegorz Sumara, Roméo Ricci, Ivan Formentini et al.|Cell|2009Cited by 245
Abstract 3845: Antitumor activity of SEL120: An orally available dual inhibitors of Haspin/CDK9, for standalone and combination therapy with AuroraB inhibitors in solid tumors and hematopoietic malignanciesTomasz Rzymski, Nicolas Beuzen, Agnieszka Kłosowska‐Wardęga et al.|Cancer Research|2012Cited by 3
P4–424: Targeting kinases hyperphosphorylating tau protein: Elucidation of kinase inhibition profile most efficient in restoring physiological tau phosphorylationMateusz Nowak, Renata Windak, Charles‐Henry Fabritius et al.|Alzheimer s & Dementia|2013Cited by 1
Abstract B242: Antitumor activity of SEL120: An orally available small-molecule inhibitor of Haspin kinase for standalone and combination therapy with AuroraB inhibitors in colorectal cancer.Tomasz Rzymski, Krzysztof Brzózka, Renata Windak et al.|Molecular Cancer Therapeutics|2011Cited by 0
Abstract 755: Repression of tumor survival pathways by novel and selective inhibitors of MNK1 and MNK2 kinases in glioblastoma and colorectal cancerTomasz Rzymski, Krzysztof Brzózka, Małgorzata Szajewska-Skuta et al.|Cancer Research|2014Cited by 0